Catalysts for Bionpharma Inc
80 tracked
Apr 8, 2026
approval
VALPROIC ACID — FDA approval
VALPROIC ACID
→
Mar 31, 2026
approval
STAVZOR (VALPROIC ACID) — FDA approval
VALPROIC ACID
→
Mar 2, 2026
approval
IMODIUM MULTI-SYMPTOM RELIEF (LOPERAMIDE HYDROCHLORIDE) — FDA approval
Bionpharma Inc
→
Jan 30, 2026
approval
CETIRIZINE HYDROCHLORIDE ALLERGY (CETIRIZINE HYDROCHLORIDE) — FDA approval
CETIRIZINE HYDROCHLORIDE
→
Jan 15, 2026
approval
NAPROXEN SODIUM — FDA approval
NAPROXEN SODIUM
→
Dec 23, 2025
approval
GLYCOPYRROLATE — FDA approval
GLYCOPYRROLATE
→
Oct 2, 2025
approval
ETRAVIRINE — FDA approval
ETRAVIRINE
→
Sep 19, 2025
approval
LOPERAMIDE HYDROCHLORIDE — FDA approval
LOPERAMIDE HYDROCHLORIDE
→
Jan 14, 2022
approval
VALPROIC ACID — FDA approval
VALPROIC ACID
→
Jan 14, 2022
approval
VALPROIC ACID — FDA approval
VALPROIC ACID
→
Dec 13, 2021
approval
NAPROXEN SODIUM — FDA approval
NAPROXEN SODIUM
→
Nov 30, 2021
approval
STAVZOR (VALPROIC ACID) — FDA approval
VALPROIC ACID
→
Dec 12, 2020
approval
NAPROXEN SODIUM — FDA approval
NAPROXEN SODIUM
→
Dec 7, 2020
approval
CETIRIZINE HYDROCHLORIDE ALLERGY (CETIRIZINE HYDROCHLORIDE) — FDA approval
CETIRIZINE HYDROCHLORIDE
→
Apr 30, 2020
approval
NAPROXEN SODIUM — FDA approval
NAPROXEN SODIUM
→
Feb 27, 2020
approval
NAPROXEN SODIUM — FDA approval
NAPROXEN SODIUM
→
Dec 26, 2019
approval
STAVZOR (VALPROIC ACID) — FDA approval
VALPROIC ACID
→
Dec 13, 2019
approval
CETIRIZINE HYDROCHLORIDE ALLERGY (CETIRIZINE HYDROCHLORIDE) — FDA approval
CETIRIZINE HYDROCHLORIDE
→
Dec 9, 2019
approval
NAPROXEN SODIUM — FDA approval
NAPROXEN SODIUM
→
Dec 9, 2019
approval
VALPROIC ACID — FDA approval
VALPROIC ACID
→
Dec 9, 2019
approval
VALPROIC ACID — FDA approval
VALPROIC ACID
→
Dec 9, 2019
approval
VALPROIC ACID — FDA approval
VALPROIC ACID
→
Dec 9, 2019
approval
VALPROIC ACID — FDA approval
VALPROIC ACID
→
Dec 9, 2019
approval
VALPROIC ACID — FDA approval
VALPROIC ACID
→
Oct 26, 2019
approval
NAPROXEN SODIUM — FDA approval
NAPROXEN SODIUM
→
Feb 20, 2019
approval
NAPROXEN SODIUM — FDA approval
NAPROXEN SODIUM
→
Dec 11, 2018
approval
IMODIUM MULTI-SYMPTOM RELIEF (LOPERAMIDE HYDROCHLORIDE) — FDA approval
Bionpharma Inc
→
Nov 29, 2018
approval
NAPROXEN SODIUM — FDA approval
NAPROXEN SODIUM
→
Apr 12, 2017
approval
IMODIUM MULTI-SYMPTOM RELIEF (LOPERAMIDE HYDROCHLORIDE) — FDA approval
Bionpharma Inc
→
Mar 16, 2017
approval
NAPROXEN SODIUM — FDA approval
NAPROXEN SODIUM
→